AXON - Axon Enterprise, Inc. Stock Analysis | Stock Taper
Logo
Axon Enterprise, Inc.

AXON

Axon Enterprise, Inc. NASDAQ
$542.40 -1.42% (-7.79)

Market Cap $43.61 B
52w High $885.92
52w Low $396.41
P/E 356.84
Volume 1.68M
Outstanding Shares 80.40M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q4-2025 $796.72M $451.3M $3M 0.38% $0.04 $55.82M
Q3-2025 $710.64M $429.48M $-2.19M -0.31% $-0.03 $64.22M
Q2-2025 $668.54M $402.68M $36.12M 5.4% $0.46 $6.96M
Q1-2025 $603.63M $373.63M $87.98M 14.58% $1.14 $135.66M
Q4-2024 $575.14M $361.5M $135.18M 23.5% $1.77 $104.07M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q4-2025 $1.71B $7B $3.76B $3.24B
Q3-2025 $2.38B $6.66B $3.63B $3.03B
Q2-2025 $2.23B $6.22B $3.48B $2.73B
Q1-2025 $2.37B $6.08B $3.53B $2.56B
Q4-2024 $986.35M $4.47B $2.15B $2.33B

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q4-2025 $2.75M $217.24M $-226.44M $-215.56M $-222.75M $155.43M
Q3-2025 $-2.19M $60.01M $590.26M $159.16M $808.68M $33.38M
Q2-2025 $36.12M $-91.7M $-386.53M $-4.37M $-477.3M $-114.66M
Q1-2025 $87.98M $25.79M $-702.22M $1.31B $638M $932K
Q4-2024 $135.18M $250.17M $-441.74M $-32.83M $-230.69M $225.37M

Revenue by Products

Product Q3-2024Q1-2025Q2-2025Q3-2025
Software and Sensors Segment
Software and Sensors Segment
$320.00M $260.00M $290.00M $310.00M
Taser Weapons Segment
Taser Weapons Segment
$220.00M $340.00M $380.00M $0

Revenue by Geography

Region Q1-2025Q2-2025Q3-2025Q4-2025
NonUS
NonUS
$70.00M $130.00M $120.00M $150.00M
UNITED STATES
UNITED STATES
$530.00M $540.00M $590.00M $640.00M

Q4 2025 Earnings Call Summary

Read Call Summary

5-Year Trend Analysis

A comprehensive look at Axon Enterprise, Inc.'s financial evolution and strategic trajectory over the past five years.

+ Strengths

Axon combines a sizeable and growing revenue base with attractive gross margins, giving it strong underlying unit economics. It holds a robust balance sheet characterized by high liquidity, moderate leverage, and meaningful retained earnings, which together provide financial flexibility. Competitively, it occupies a leadership position in public safety technology with an integrated ecosystem of hardware, cloud software, and AI that creates significant switching costs and network effects. Positive operating and free cash flow—despite ongoing operating losses—indicate that the business model is already generating real cash, even as the company invests heavily in innovation and expansion.

! Risks

Key risks center on profitability, concentration, and complexity. Core operations are currently unprofitable, with net income flattered by tax benefits rather than sustainable operating earnings, and high levels of SG&A and R&D spending must eventually be justified by faster revenue growth and operating leverage. The business is highly exposed to government and public safety budgets and to evolving political and regulatory attitudes toward policing, surveillance, AI, and use-of-force tools. A large portion of the asset base consists of goodwill and other intangibles from acquisitions, which introduces integration and impairment risk, while the heavy reliance on external financing to support ambitious investment plans adds sensitivity to capital market conditions.

Outlook

The overall outlook for Axon is that of a financially solid, innovation‑driven leader operating in a sensitive but structurally important niche. If the company can continue to grow its ecosystem, successfully execute its AI and software roadmap, and scale revenue faster than operating expenses, its strong gross margins and recurring revenue model provide a path toward much healthier profitability. At the same time, outcomes are uncertain and will be influenced by regulatory developments, public sentiment around law enforcement technology, competitive responses from large incumbents and new entrants, and the integration success of multiple acquisitions. Stakeholders should view Axon as a company with substantial long‑term opportunity but also meaningful execution and regulatory risk that could materially affect future financial performance.